KLI

Genomic Association Study for Cognitive Impairment in Parkinson's Disease

Metadata Downloads
Abstract
Background: Cognitive impairment is very common in Parkinson's disease (PD) and constitutes the most debilitating complication of this disease. However, to date, few studies have investigated a genome-wide association in the development of cognitive impairment of PD. We aimed to identify the genetic loci associated with cognitive impairment in patients with sporadic PD by ethnicity-specific genotyping.

Materials and methods: We recruited 1,070 patients with PD and performed a genome-wide association study using the Korean Chip, a microarray chip containing 827,400 single-nucleotide polymorphisms (SNPs) optimized for the Korean population. Multiple logistic regression models adjusting for age, sex, years of education, and disease duration were used to compare between patients with and without cognitive impairment, which was defined using the Mini-Mental Status Examination (MMSE) score (MMSE score >= 26 vs. < 26) or the Montreal Cognitive Assessment (MoCA) score (MoCA score >= 24 vs. < 24).

Results: RYR2 SNP rs10495397 was most significantly associated with cognitive impairment based on the MMSE scores (OR = 3.21; 95% CI = 1.96-5.25, P = 3.36 x 10(-6)) and CASC17 showed the strongest association with cognitive impairment based on the MoCA scores. However, none of the SNPs were statistically significant after Bonferroni correction.

Conclusion: RYR2 may play a role in cognitive impairment in PD by the pathogenic mechanism of neuroinflammation. However, more studies are needed to replicate and validate the results of our functional study.
Author(s)
이재홍전상용정선주Ho-Sung RyuJinhee KimKye Won ParkMi Sun KimSeong-Beom KohSungyang JoYoung-Min Park
Issued Date
2021
Type
Article
Keyword
Parkinson's diseasecognitive impairmentdementiagenome-wide association studiesryanodine receptor
DOI
10.3389/fneur.2020.579268
URI
https://oak.ulsan.ac.kr/handle/2021.oak/7838
https://ulsan-primo.hosted.exlibrisgroup.com/primo-explore/fulldisplay?docid=TN_cdi_doaj_primary_oai_doaj_org_article_dc335eca899c4304a3b057dda5329564&amp;context=PC&amp;vid=ULSAN&amp;lang=ko_KR&amp;search_scope=default_scope&amp;adaptor=primo_central_multiple_fe&amp;tab=default_tab&amp;query=any,contains,Genomic%20Association%20Study%20for%20Cognitive%20Impairment%20in%20Parkinson%27s%20Disease&amp;offset=0&amp;pcAvailability=true
Publisher
FRONTIERS IN NEUROLOGY
Location
스위스
Language
영어
ISSN
1664-2295
Citation Volume
11
Citation Number
0
Citation Start Page
0
Citation End Page
0
Appears in Collections:
Medicine > Medicine
공개 및 라이선스
  • 공개 구분공개
파일 목록
  • 관련 파일이 존재하지 않습니다.

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.